Spero Therapeutics (SPRO) Q2 2024 Earnings

15MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.34
0.09
0.53
0.96

Details

Expected EPS
-0.043333
Actual EPS
-0.24
Surprise EPS
-0.2
Surprise Percent
+453.85%

Description

Spero Therapeutics (SPRO) has reported earnings of -0.24 per share for Q2 2024.

0 Comments

Share your thoughts